On ECHEMI
Home > Drugs > Verrucous skin tuberculosis
Verrucous skin tuberculosis
Verrucous cutaneous tuberculosis is a proliferative skin lesion that occurs after Mycobacterium tuberculosis directly infects the skin through skin trauma. The course of the disease is slow, and it is a benign type of cutaneous tuberculosis. It is caused by exogenous reinfection of Mycobacterium tuberculosis in an immune body, causing it to produce localized verrucous cutaneous tuberculosis. It is more common in adults, especially in men (70.8%), and the incidence rate is higher in those who have direct contact with tuberculosis patients or tuberculosis animals. Infection is common in exposed areas, most commonly on the back of the hands and fingers. The characteristics of the lesion are: it initially manifests as a single papule, and the central horny layer gradually thickens and presents a warty hyperplasia. The course of the disease is extremely slow and often does not heal for many years.
Related Drugs
Pasniazid Capsules
Indication: This product is suitable for use in combination with other anti-tuberculosis drugs to treat various types of tuberculosis in adults and children, and can also be used as a preventive drug during surgical operations.
Manufacturer:

Shanghai Huangxiang Tieli Blue Sky Pharmaceutical Co., Ltd.

Prothionamide Enteric-coated Tablets
Indication: This product is only effective against mycobacteria. It is used in combination with other anti-tuberculosis drugs for patients with tuberculosis who have not responded to first-line treatment with drugs (such as streptomycin, isoniazid, rifampicin and ethambutol).
Pyrazinamide Capsules
Indication: This product is only effective against mycobacteria and is used in combination with other anti-tuberculosis drugs (such as streptomycin, isoniazid, rifampicin and ethambutol) to treat tuberculosis.
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.